Products & Tech | Page 34 of 63

Lilly Diabetes Launches Glucagon Mobile App

Lilly Diabetes today announced the release of a new mobile application designed for caregivers and healthcare providers who support people with type 1 diabetes. The Lilly Glucagon Mobile App is a tool to teach how to use Glucagon for injection, through simulated practice. Glucagon, 1 mg (1 unit), is indicated to treat severe hypoglycemia (low blood sugar). Severe hypoglycemia due to insulin may result in loss of consciousness (insulin coma).

Omnipod Put to the Test

I have been extremely happy with the Omnipod and require less insulin than I used to because I never detach. I feel that my work outs are better now and I am more comfortable in my daily routine. In April of this year, I decided sign up for run my first “Mudder” race called the Rugged Maniac. The Rugged Maniac is a 5K mud run full of military-style obstacles, designed by British Special Forces.

FDA approves Lucentis for Diabetic Macular Edema

The U.S. FDA has approved Roche's Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes. The FDA previously had approved Lucentis to treat wet (neovascular) age-related macular degeneration (AMD), a condition in which abnormal blood vessels grow and leak fluid into the macula. Lucentis also is approved to treat macular edema following retinal vein occlusion...

Positive Results for Echo Therapeutics’ Transdermal Continuous Glucose Monitoring System

Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients. Data from this study demonstrate that Symphony successfully and continuously monitored glucose levels in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.

Medtronic’s Enlite Sensor: The Waiting is the Hardest Part

First, the new Enlite sensor — and I really should use “new” in quotation marks because it has been available in Europe for about a year — is much more comfortable and accurate than previous Minimed sensors. Second, the Veo pump itself has a glucose suspend feature, meaning that if the Enlite sensor detects your blood glucose is below 70, it can stop insulin delivery on its own.

Pumping Insulin, The Fifth Edition

We recently received a copy of Pumping Insulin, the 5th Edition, which provides up-to-date information on how to use an insulin pump to achieve the best blood glucose management. The book provides clear, logical steps on how to set up a pump test and adjust it. It demonstrates simple ways to find your total daily dose of insulin, basal rate and carb and correction factors for boluses, and how to use the bolus calculator to avoid stacking insulin and highs and lows.

GlucoLift Glucose Tablets: The Natural Way to Treat Hypoglycemia

Well, there are two ways to look at our differences. One is to list things, like the fact that we don't use any artificial flavors, or petroleum-derived food dyes, that we use a glucose that dissolves cleanly, without a chalky aftertaste, that we use delicious, natural flavors, or that we use flip-tops instead of plugs or screw caps- those are some of the attributes that makes GlucoLift different, but really it all comes down to the fact that our tablets are designed from the point of view of the end user, not by a big company.

NIH Awards Biodel Grant to Develop Ultra-Rapid-Acting Insulin for Use in Artificial Pancreas

The Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.

Jentadueto Approved in Europe for Treatment of Adults with Type 2 Diabetes

The European Commission has given Marketing Authorization to Jentadueto (linagliptin/metformin hydrochloride) tablets,Boehringer Ingelheim and Eli Lilly's medicine combining the DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta tablets, marketed under the trade name Trajenta in Europe) and metformin in a single tablet taken twice daily.

First Impressions of Tandem’s t:slim Insulin Pump

I spent most of my time with the t:slim going through the screens like a kid with a new toy. I felt like I did when I got my first iPhone, and I think one of the best things about the pump was the enthusiastic response I got from people around me. Everyone wanted to see it. Okay, it’s true, most of the people around me had diabetes, but still, everyone there had seen insulin pumps before.